Investor Overview

NASDAQ: XBIT0.4913.76Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
11/17/16XBiotech Announces Research Collaboration with Renowned GastroenterologistPrinter Friendly Version
11/10/16XBiotech to Provide Third Quarter 2016 Business Update on November 15Printer Friendly Version
10/12/16XBiotech Announces Successful Completion of EMA GMP InspectionPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »